Amneal Pharmaceuticals (AMRX) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to -$133.5 million.
- Amneal Pharmaceuticals' Enterprise Value fell 84531.48% to -$133.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$133.5 million, marking a year-over-year decrease of 84531.48%. This contributed to the annual value of -$45.6 million for FY2024, which is 929.57% up from last year.
- Amneal Pharmaceuticals' Enterprise Value amounted to -$133.5 million in Q3 2025, which was down 84531.48% from -$5.7 million recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Enterprise Value registered a high of $13.4 million during Q1 2025, and its lowest value of -$439.0 million during Q1 2021.
- In the last 5 years, Amneal Pharmaceuticals' Enterprise Value had a median value of -$65.0 million in 2022 and averaged -$106.6 million.
- As far as peak fluctuations go, Amneal Pharmaceuticals' Enterprise Value tumbled by 479279.45% in 2023, and later surged by 257410.36% in 2025.
- Amneal Pharmaceuticals' Enterprise Value (Quarter) stood at -$230.9 million in 2021, then skyrocketed by 99.56% to -$1.0 million in 2022, then crashed by 4792.79% to -$50.2 million in 2023, then increased by 9.3% to -$45.6 million in 2024, then plummeted by 192.84% to -$133.5 million in 2025.
- Its last three reported values are -$133.5 million in Q3 2025, -$5.7 million for Q2 2025, and $13.4 million during Q1 2025.